List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 7889 studies with search of: NCI
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting AT13387 in Treating Patients With Refractory Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Hsp90 inhibitor AT13387;   Other: laboratory biomarker analysis;   Other: pharmacological study
2 Recruiting Lenalidomide and Radiation Therapy in Treating Young Patients With Pontine Glioma or High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lenalidomide;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Radiation: radiation therapy
3 Recruiting Bevacizumab and Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin in Treating Patients With Refractory Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: polyethyleneglycol-7-ethyl-10-hydroxycamptothecin;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis
4 Recruiting GVAX Pancreas Vaccine With or Without CRS-207 for Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Neoplasms, Pancreatic;   Pancreatic Neoplasms
Interventions: Drug: Cyclophosphamide;   Biological: GVAX Pancreas Vaccine;   Biological: CRS-207
5 Completed Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
Conditions: Acquired Immunodeficiency Syndrome;   Alcoholism;   HIV Infection;   Neoplasm;   Smoking
Intervention:
6 Completed A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin;   Drug: ifosfamide;   Drug: mesna
7 Completed Raloxifene in Preventing Breast Cancer in Premenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Procedure: evaluation of cancer risk factors
8 Completed UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: 7-hydroxystaurosporine;   Drug: prednisone
9 Completed Chemotherapy Consisting of Fludarabine and Cyclophosphamide Followed By White Blood Cell Infusion, Vaccine Therapy, and Aldesleukin in Treating Patients With Recurrent or Refractory Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: fowlpox virus vaccine vector;   Biological: gp100 antigen;   Biological: therapeutic autologous lymphocytes;   Biological: therapeutic tumor infiltrating lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
10 Completed A Case-Referent Study of Brain Tumors in Adults
Condition: Brain Tumors
Intervention:
11 Active, not recruiting Continuation of Follow-up of DES-Exposed Cohorts
Condition: Diethylstilbestrol (DES) Exposure
Intervention:
12 Completed Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
Conditions: Chromosomal Aberrations;   Cosmic Radiation
Intervention:
13 Unknown † DNA Analysis of Blood Samples From Patients With Cancer Previously Treated With Imatinib Mesylate
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: imatinib mesylate;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
14 Recruiting Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
Conditions: Hodgkin Lymphoma;   Diffuse Large B-Cell Lymphoma
Interventions: Drug: Cylcophosphamide;   Drug: Etoposide;   Drug: Alemtuzumab;   Drug: Doxorubicin;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Rituximab;   Drug: Vincristine
15 Completed A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
Conditions: Colon Cancer;   Lung Cancer;   Cervical Cancer;   Renal Cell Carcinoma;   Uterine Cancer
Intervention: Drug: (18)Fluciclatide
16 Recruiting BRCA Mutations in Latinas
Condition: Breast Neoplasms
Intervention:
17 Recruiting Environmental and Genetic Determinants of NPC
Condition: NPC
Intervention:
18 Recruiting Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Conditions: Breast Cancer;   Colon Cancer;   Bladder Cancer
Interventions: Drug: Glycosylated Recombinant Human Interleukin-7;   Biological: Diphtheria-Tetanus Vaccine;   Biological: Polio Vaccine;   Biological: Pneumaococcal Vaccine;   Biological: Hepatitis A Vaccine;   Biological: Hepatitis B Vaccine;   Biological: Influenza Vaccine;   Biological: PhiX 174
19 Completed Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
Condition: Lymphoma, Non-Hodgkin
Intervention:
20 Completed Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
Condition: Cryptococcosis
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services